Phase II clinical trial using novel peptide cocktail vaccine as a postoperative adjuvant treatment for surgically resected pancreatic cancer patients

International Journal of Cancer ◽

10.1002/ijc.30510 ◽

2016 ◽

Vol 140 (4) ◽

pp. 973-982 ◽

Author(s):

Motoki Miyazawa ◽

Masahiro Katsuda ◽

Hiroyuki Maguchi ◽

Akio Katanuma ◽

Hiroshi Ishii ◽

...

Keyword(s):

Pancreatic Cancer ◽

Clinical Trial ◽

Cancer Patients ◽

Phase Ii ◽

Adjuvant Treatment ◽

Phase Ii Clinical Trial ◽

Postoperative Adjuvant Treatment

Download Full-text

Phase II clinical trial using novel peptide vaccine cocktail as a postoperative adjuvant treatment for surgically resected pancreatic cancer patients.

Journal of Clinical Oncology ◽

10.1200/jco.2016.34.15_suppl.e14587 ◽

2016 ◽

Vol 34 (15_suppl) ◽

pp. e14587-e14587 ◽

Author(s):

Hiroki Yamaue ◽

Motoki Miyazawa ◽

Masahiro Katsuda ◽

Hiroyuki Maguchi ◽

Hiroshi Ishii ◽

...

Keyword(s):

Pancreatic Cancer ◽

Clinical Trial ◽

Cancer Patients ◽

Phase Ii ◽

Adjuvant Treatment ◽

Peptide Vaccine ◽

Phase Ii Clinical Trial ◽

Postoperative Adjuvant Treatment

Download Full-text

A Phase II clinical trial to compare the effectiveness of gemcitabine and nab-paclitaxel administered in combination with ATRA vs without ATRA in patients with locally advanced treatment-naïve pancreatic cancer

http://isrctn.com/ ◽

10.1186/isrctn11503604 ◽

2021 ◽

Author(s):

Hemant Kocher

Keyword(s):

Pancreatic Cancer ◽

Clinical Trial ◽

Phase Ii ◽

Locally Advanced ◽

Phase Ii Clinical Trial ◽

Advanced Treatment ◽

Treatment Naïve

Download Full-text

Induced chemotherapy plus consolidative chemoradiotherapy is an optimal regimen for locally advanced pancreatic cancer A single institutional prospective phase II clinical trial

Pancreatology ◽

10.1016/j.pan.2018.05.367 ◽

2018 ◽

Vol 18 (4) ◽

pp. S136

Author(s):

Wenhui Lou ◽

Lili Wu ◽

Yuhong Zhou

Keyword(s):

Pancreatic Cancer ◽

Clinical Trial ◽

Phase Ii ◽

Locally Advanced ◽

Advanced Pancreatic Cancer ◽

Phase Ii Clinical Trial ◽

Locally Advanced Pancreatic Cancer ◽

Prospective Phase ◽

Optimal Regimen

Download Full-text

Phyllanthus niruri Linn increase infiltrating lymphocyte and apoptosis of rectosigmoid cancer patients. A phase II clinical trial

Bali Medical Journal ◽

10.15562/bmj.v6i3.674 ◽

2017 ◽

Vol 6 (3) ◽

pp. 509

Author(s):

Ignatius Riwanto ◽

Parish Budiono ◽

Abdul Mughni ◽

Martahadinan Martahadinan ◽

Nugrahanta Dasa Putra ◽

...

Keyword(s):

Clinical Trial ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Clinical Trial ◽

Phyllanthus Niruri ◽

Rectosigmoid Cancer

Download Full-text

Phase II Clinical Trial to Evaluate the Efficacy and Safety of Activated T-Lymphocyte Cell Therapy in Gemcitabine Refractory Advanced Pancreatic Cancer

Gastroenterology ◽

10.1016/s0016-5085(11)62815-1 ◽

2011 ◽

Vol 140 (5) ◽

pp. S-679

Author(s):

Moon Jae Chung ◽

Jeong Youp Park ◽

Seungmin Bang ◽

Seung Woo Park ◽

Jae Bock Chung ◽

...

Keyword(s):

Pancreatic Cancer ◽

Clinical Trial ◽

Cell Therapy ◽

Phase Ii ◽

T Lymphocyte ◽

Advanced Pancreatic Cancer ◽

Phase Ii Clinical Trial ◽

Efficacy And Safety ◽

Gemcitabine Refractory ◽

Lymphocyte Cell

Download Full-text

Abstract CT302: A phase II clinical trial of weekly paclitaxel and carboplatin in combination with panitumumab in metastatic or recurrent breast cancer patients with triple negative disease

10.1158/1538-7445.am2014-ct302 ◽

2014 ◽

Author(s):

Stacy Cowherd ◽

Susan Melin ◽

Steven Akman ◽

John Cole ◽

Julia Lawrence

Keyword(s):

Breast Cancer ◽

Clinical Trial ◽

Cancer Patients ◽

Phase Ii ◽

Triple Negative ◽

Recurrent Breast Cancer ◽

Phase Ii Clinical Trial ◽

Weekly Paclitaxel ◽

Breast Cancer Patients ◽

Recurrent Breast

Download Full-text

A dynamic portrait of adverse events for breast cancer patients: results from a phase II clinical trial of eribulin in advanced HER2-negative breast cancer

Breast Cancer Research and Treatment ◽

10.1007/s10549-020-05928-4 ◽

2020 ◽

Author(s):

Otto Metzger Filho ◽

Anita Giobbie-Hurder ◽

Nancy U. Lin ◽

Meredith Faggen ◽

Steven Come ◽

...

Keyword(s):

Breast Cancer ◽

Clinical Trial ◽

Adverse Events ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Clinical Trial ◽

Breast Cancer Patients

Download Full-text

A Phase II Clinical Trial of Flutamide in the Treatment of Advanced Breast Cancer

Tumori Journal ◽

10.1177/030089168807400109 ◽

1988 ◽

Vol 74 (1) ◽

pp. 53-56 ◽

Author(s):

Tiping Zhao ◽

Guifen He

Keyword(s):

Breast Cancer ◽

Clinical Trial ◽

Advanced Breast Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Transient Response ◽

Postmenopausal Breast Cancer ◽

Phase Ii Clinical Trial ◽

Advanced Breast ◽

Breast Cancer Patients

An antiandrogenic agent flutamide was used in the treatment of one male and 14 female postmenopausal breast cancer patients. Only a mild and transient response was seen in 2 female patients. Therefore, flutamide cannot be used solely in the treatment of female postmenopausal breast cancer.

Download Full-text

Cardiac MRI for Evaluation of Radiation-Induced Cardiotoxicity in Breast Cancer Patients: A Phase II Clinical Trial

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2019.06.2398 ◽

2019 ◽

Vol 105 (1) ◽

pp. E59-E60

Author(s):

C. Speers ◽

V.L. Murthy ◽

E.M. Walker ◽

E. Morris ◽

C. Glide-Hurst ◽

...

Keyword(s):

Breast Cancer ◽

Clinical Trial ◽

Cancer Patients ◽

Phase Ii ◽

Cardiac Mri ◽

Phase Ii Clinical Trial ◽

Breast Cancer Patients ◽

Radiation Induced

Download Full-text

Phase II Clinical Trial of 5-Fluorouracil, Trimetrexate, and Leucovorin (NFL) in Patients With Advanced Pancreatic Cancer

International Journal of Gastrointestinal Cancer ◽

10.1385/ijgc:34:2-3:079 ◽

2003 ◽

Vol 34 (2-3) ◽

pp. 079-086 ◽

Author(s):

Agustin A. Garcia ◽

Lawrence Leichman ◽

Joaquina Baranda ◽

Lalita Pandit ◽

Heinz-Josef Lenz ◽

...

Keyword(s):

Pancreatic Cancer ◽

Clinical Trial ◽

Phase Ii ◽

Advanced Pancreatic Cancer ◽

Phase Ii Clinical Trial

Download Full-text